The 16th Skin Academy conference, held on 22 to 23 March in Barcelona, Spain by Almirall, highlighted collaboration and the development of new methods and solutions in the field of dermatology.

The event brought together a broad range of experts and clinicians from across the world, with this year’s offering featuring a programme aimed at sharing scientific knowledge on skin diseases, their treatment and clinical best practice.

Among the diseases covered in this year’s programme was actinic keratosis (AK), the most common precancerous skin condition, characterised by rough, scaly patches of skin that commonly develop on the most exposed areas of the body.

The Skin Academy conference highlighted the importance of early treatment in AK to prevent its progression to squamous cell carcinoma, with experts focusing on advancements in treatment, real-world evidence and the importance of patient satisfaction in treatment outcomes.

Psoriasis, an immune-mediated disease that causes inflammation in the body, was another key focus at this year’s event, with sessions dedicated to biologic treatments.

Topics on other dermatological conditions, including atopic dermatitis, androgenetic alopecia, onychomycosis and chronic spontaneous urticaria, were also included in the programme.

Almirall’s chief medical officer, Volker Koscielny, said: “This is the 16th edition of the Skin Academy, and we are proud to continue to provide a leading platform for exchange and advancement in medical dermatology.

“Skin Academy fosters collaboration and co-creation of innovative approaches and solutions that help the medical dermatology community to better respond to the unmet needs of millions of people living with these conditions.”